Van Hecken, A <br/><br/>
Comparative inhibitory activity of rofecoxib, meloxicam, diclofenac, ibuprofen, and naproxen on COX-2 versus COX-1 in healthy volunteers.  [electronic resource] 

 -  Journal of clinical pharmacology  Oct 2000 
 - 1109-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0091-2700 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Bleeding Time<br/>Cyclooxygenase 1<br/>Cyclooxygenase 2<br/>Cyclooxygenase 2 Inhibitors<br/>Cyclooxygenase Inhibitors--adverse effects<br/>Diclofenac--adverse effects<br/>Dinoprostone--metabolism<br/>Female<br/>Humans<br/>Ibuprofen--adverse effects<br/>Isoenzymes--antagonists & inhibitors<br/>Lactones--adverse effects<br/>Lipopolysaccharides--pharmacology<br/>Meloxicam<br/>Membrane Proteins<br/>Middle Aged<br/>Naproxen--adverse effects<br/>Platelet Aggregation--drug effects<br/>Prostaglandin-Endoperoxide Synthases--metabolism<br/>Prostaglandins--urine<br/>Sulfones<br/>Thiazines--adverse effects<br/>Thiazoles--adverse effects<br/>Thromboxane B2--blood